The Role of Dermacyn Solution in the Treatment of Infected Diabetic Foot Ulcers in Basrah: A Randomized Clinical Trial Study

Dermacyn (super-oxidized solution) is a new therapy used as topical dressing in open wounds. The aim of the study is to assess the effectiveness of Dermacyn solution as topical dressing in infected diabetic foot ulcers (DFUs). This is a randomized clinical trial study, done in Al-Fayha Diabetic Foot Clinic between Jan. 2018till May 2019. Sixty-six adult Type 2 diabetic patients divided into two groups, group A (n = 33) using (Dermacyn) while in group B (n = 33) using Normal Saline (N/S). Mean age of patients (52.65+ 8.14) years. Most of patients in group A (81.8%) are improved with healed ulcers while (48.5%) of patients in group B with the same outcome with significant statistical difference.

There is very significant statistical difference in healing time between group A (Dermacyn) (40.74+3.84) days and group B (N/S) (51+3.41) days. The Dermacyn was effective.